SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-402289
Filing Date
2012-09-25
Accepted
2012-09-25 06:22:01
Documents
8
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d401713d10q.htm 10-Q 640237
2 SPECIMEN OF STOCK CERTIFICATE d401713dex42.htm EX-4.2 736
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d401713dex311.htm EX-31.1 9407
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER d401713dex312.htm EX-31.2 9267
5 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER d401713dex321.htm EX-32.1 4429
6 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER d401713dex322.htm EX-32.2 4309
7 GRAPHIC g401713g26u41.jpg GRAPHIC 55557
8 GRAPHIC g401713g61t65.jpg GRAPHIC 114455
  Complete submission text file 0001193125-12-402289.txt   903919
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54735 | Film No.: 121107679
SIC: 2834 Pharmaceutical Preparations